CREDIT SUISSE AG/ - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$2,562,216
-26.0%
207,299
-3.7%
0.00%0.0%
Q2 2023$3,460,819
+8.1%
215,359
+17.2%
0.00%0.0%
Q1 2023$3,200,498
+132.5%
183,831
+23.4%
0.00%
+200.0%
Q4 2022$1,376,566
+29.5%
148,979
+20.6%
0.00%0.0%
Q3 2022$1,063,000
-74.5%
123,496
-75.9%
0.00%
-75.0%
Q2 2022$4,169,000
+178.3%
511,446
+314.6%
0.00%
+300.0%
Q1 2022$1,498,000
-59.4%
123,359
+14.2%
0.00%
-50.0%
Q4 2021$3,687,000
-30.2%
108,031
-1.4%
0.00%
-33.3%
Q3 2021$5,284,000
-26.8%
109,528
-31.5%
0.00%
-25.0%
Q2 2021$7,219,000
+11.5%
159,835
+19.0%
0.00%
+33.3%
Q1 2021$6,477,000
-11.5%
134,272
-1.3%
0.00%
-25.0%
Q4 2020$7,321,000
+34.5%
136,017
-7.8%
0.00%
+33.3%
Q3 2020$5,444,000
+40.1%
147,549
+17.6%
0.00%0.0%
Q2 2020$3,886,000
+49.9%
125,463
+33.6%
0.00%
+50.0%
Q1 2020$2,592,000
-16.9%
93,899
-12.0%
0.00%0.0%
Q4 2019$3,120,000
+69.7%
106,675
+10.9%
0.00%0.0%
Q3 2019$1,838,000
-21.6%
96,168
-9.9%
0.00%0.0%
Q2 2019$2,343,000
+20.5%
106,790
+12.4%
0.00%0.0%
Q1 2019$1,944,000
+60.7%
95,011
-1.0%
0.00%
+100.0%
Q4 2018$1,210,000
+36.3%
95,988
+65.8%
0.00%0.0%
Q3 2018$888,000
-10.7%
57,890
-23.6%
0.00%0.0%
Q2 2018$994,000
+38.6%
75,776
-13.8%
0.00%0.0%
Q1 2018$717,000
+5.9%
87,906
+15.2%
0.00%0.0%
Q4 2017$677,000
-8.0%
76,334
+15.6%
0.00%0.0%
Q3 2017$736,000
+150.3%
66,056
+101.6%
0.00%
Q2 2017$294,000
-19.2%
32,767
-29.0%
0.00%
Q1 2017$364,000
-31.7%
46,182
-25.6%
0.00%
-100.0%
Q4 2016$533,000
+4.3%
62,097
+0.1%
0.00%
Q3 2016$511,000
-47.9%
62,060
-49.1%
0.00%
-100.0%
Q2 2016$980,000
+605.0%
121,896
+591.5%
0.00%
Q4 2015$139,000
+9.4%
17,627
-20.8%
0.00%
Q3 2015$127,000
-3.1%
22,244
-8.2%
0.00%
Q2 2015$131,000
-77.6%
24,220
-80.7%
0.00%
-100.0%
Q1 2015$586,000
+55.0%
125,372
+38.5%
0.00%
Q4 2014$378,000
+101.1%
90,534
+150.2%
0.00%
Q3 2014$188,000
-18.6%
36,178
-48.1%
0.00%
Q2 2014$231,000
+148.4%
69,766
+159.4%
0.00%
Q1 2014$93,000
-11.4%
26,896
-8.0%
0.00%
Q4 2013$105,000
+118.8%
29,232
+83.5%
0.00%
Q3 2013$48,000
-25.0%
15,934
-0.2%
0.00%
Q2 2013$64,000
+48.8%
15,972
+46.5%
0.00%
Q1 2013$43,00010,9000.00%
Other shareholders
NEOGENOMICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,516,313$14,0118.43%
Greenhouse Funds LLLP 2,795,231$25,827,9342.36%
First Light Asset Management, LLC 2,682,171$24,783,2602.30%
PERKINS CAPITAL MANAGEMENT INC 197,700$1,8271.93%
Altium Capital Management LP 285,000$2,633,4001.34%
EMERALD MUTUAL FUND ADVISERS TRUST 1,654,543$15,287,9770.95%
EMERALD ADVISERS, LLC 2,101,567$19,418,4790.94%
Bullseye Asset Management LLC 105,997$9800.53%
OAK FAMILY ADVISORS, LLC 101,194$935,0330.50%
FORMULA GROWTH LTD 180,300$1,665,9720.47%
View complete list of NEOGENOMICS INC shareholders